Citation
65 FR 3466
Multiple canonical documents share this first-page citation.
- Government-Owned Invention; Availability for Licensing: “Therapeutic Methods to Treat Tumor Cells-Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activators” 65 FR 3466
- Government-Owned Invention; Availability for Licensing: “Compositions and Methods for Specifically Targeting Tumors-Using a Blocker Reagent” 65 FR 3466